| coordinators: | David S. Baldwin, United Kingdom |
| |
Wednesday 22 October 2014
| 08:00 - 15:00
| Room M2 |
| 08:00 - 09:45 | Experimental models of attachment and anxiety disorders |
| | chairs: | David S. Baldwin, United Kingdom |
| |
| 08:00 - 08:30 | The development and neurobiology of infant attachment and fear |
| | presenter: | Regina Sullivan, United States |
| |
| 08:30 - 09:00 | Influence of oxytocin and vasopresin on attachment and anxiety |
| | discussant: | Bice Chini, Italy |
| |
| 09:00 - 09:30 | The 7.5% CO2 challenge experimental medicine model |
| | discussant: | David S. Baldwin, United Kingdom |
| |
| 10:15 - 12:00 | From childhood to adult separation anxiety disorder: epidemiological aspects and relationships with other mental disorders |
| |
| 10:15 - 10:45 | Separation anxiety disorder: findings from general population studies |
| | presenter: | Katja Beesdo-Baum, Germany |
| |
| 10:45 - 11:15 | Frequency and correlates of adult separation anxiety in clinical settings |
| | discussant: | Stefano Pini, Italy |
| |
| 11:15 - 11:45 | Distinguishing separation anxiety disorder from anxiety and personality disorders |
| | discussant: | Borwin Bandelow, Germany |
| |
| 13:00 - 14:45 | From bench to practice: implications for treatment approaches |
| |
| 13:00 - 13:30 | Genetic 'dissection' of anxiety disorders |
| | presenter: | Katharina Domschke, Germany |
| |
| 13:30 - 14:00 | Oxytocin effects on the human brain: findings, questions, and future directions |
| | discussant: | Omri Weisman, United States |
| |
| 14:00 - 14:30 | New directions in pharmacological approaches to anxiety disorders |
| | discussant: | David Nutt, United Kingdom |
| |
| 14:45 - 15:00 | General discussion and closing |